Catalyst Wire Dossier Catalyst Wire Dossier

Autologous tumor lysate-loaded dendritic cell vaccine

dendritic cell vaccine (autologous tumor lysate-loaded) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous tumor lysate-loaded dendritic cell vaccine, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

See pricing